Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
Robert Putnak J, Coller BA, Voss G, Vaughn DW, Clements D, Peters I, Bignami G, Houng HS, Chen RC, Barvir DA, Seriwatana J, Cayphas S, Garçon N, Gheysen D, Kanesa-Thasan N, McDonell M, Humphreys T, Eckels KH, Prieels JP, Innis BL. Robert Putnak J, et al. Among authors: innis bl. Vaccine. 2005 Aug 15;23(35):4442-52. doi: 10.1016/j.vaccine.2005.03.042. Vaccine. 2005. PMID: 16005749
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
Srivastava AK, Putnak JR, Lee SH, Hong SP, Moon SB, Barvir DA, Zhao B, Olson RA, Kim SO, Yoo WD, Towle AC, Vaughn DW, Innis BL, Eckels KH. Srivastava AK, et al. Among authors: innis bl. Vaccine. 2001 Aug 14;19(31):4557-65. doi: 10.1016/s0264-410x(01)00208-0. Vaccine. 2001. PMID: 11483284
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.
Kanesa-Thasan N, Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Coster TS, Kim-Ahn GJ, Dubois DR, Putnak JR, King A, Summers PL, Innis BL, Eckels KH, Hoke CH Jr. Kanesa-Thasan N, et al. Among authors: innis bl. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):17-23. doi: 10.4269/ajtmh.2003.69.17. Am J Trop Med Hyg. 2003. PMID: 14740951 Clinical Trial.
Atypical antibody responses in dengue vaccine recipients.
Kanesa-Thasan N, Sun W, Ludwig GV, Rossi C, Putnak JR, Mangiafico JA, Innis BL, Edelman R. Kanesa-Thasan N, et al. Among authors: innis bl. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):32-8. doi: 10.4269/ajtmh.2003.69.32. Am J Trop Med Hyg. 2003. PMID: 14740953
Evaluation of dengue virus strains for human challenge studies.
Mammen MP, Lyons A, Innis BL, Sun W, McKinney D, Chung RC, Eckels KH, Putnak R, Kanesa-thasan N, Scherer JM, Statler J, Asher LV, Thomas SJ, Vaughn DW. Mammen MP, et al. Among authors: innis bl. Vaccine. 2014 Mar 14;32(13):1488-94. doi: 10.1016/j.vaccine.2013.12.040. Epub 2014 Jan 24. Vaccine. 2014. PMID: 24468542 Clinical Trial.
210 results